Please find attached a copy of the Draft Letter of Offer (DLOF) from SBI Capital Markets Limited, the Manager to the Open Offer.
M&A
● No Immediate Change
LOW RISK
📅 Filed on BSE: 09 Jun 2026, 07:27 PM IST · BSE ID: bb668915-1d4c-43f6-86df-4f82cc7f2a29
View Original BSE Filing (PDF)
💡
In Simple Terms
Bliss GVS Pharma has received the official document detailing Anupam Rasayan's offer to buy 26% of its shares at ₹ 299.00 each.
🤖 AI Summary
- Bliss GVS Pharma received Draft Letter of Offer (DLOF) from SBI Capital Markets Limited for an open offer.
- Anupam Rasayan India Limited is making a cash offer to acquire up to 2,77,26,848 equity shares.
- The offer price is ₹ 299.00 per equity share for public shareholders.
- The shares represent 26.00% of Bliss GVS Pharma's expanded voting share capital.
- The DLOF outlines detailed terms and conditions of the open offer in compliance with SEBI SAST Regulations, 2011.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of Equity Shares Offered
2,77,26,848
Offer Price per Equity Share
₹ 299.00
Percentage of Expanded Voting Share Capital
26.00%
🏢 How This Affects the Company
Anupam Rasayan India Limited, the acquirer, aims to take a substantial 26.00% stake in Bliss GVS Pharma Limited, which may influence future strategic direction and business operations.
The open offer involves a cash transaction at ₹ 299.00 per share, which will impact the shareholding structure without directly altering Bliss GVS Pharma's immediate balance sheet or operational cash flow.
The DLOF clarifies that the open offer is not a conditional offer nor a competing offer, reducing certain regulatory complexities for the transaction.
👥 What This Means For Shareholders
✅
Action Required
Eligible public shareholders of Bliss GVS Pharma Limited who wish to tender their equity shares in the open offer must review the detailed terms and conditions in the DLOF.
👤
Who Is Affected
Public shareholders of Bliss GVS Pharma Limited are affected, as they have the option to tender up to 2,77,26,848 of their equity shares at ₹ 299.00 per share to Anupam Rasayan India Limited.
🔍
Management Signal
The management of Bliss GVS Pharma Limited is fulfilling its regulatory obligation by disseminating the DLOF received from the Manager to the Open Offer.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
SEBI approval of the Draft Letter of Offer for the open offer.
Commencement date of the open offer for tendering shares.
Announcement of the final shareholding pattern post-open offer.
LOW RISK
This filing is a procedural step for a previously announced open offer, with no new immediate risks identified.
💡 Investor Takeaway
Bliss GVS Pharma received the Draft Letter of Offer from SBI Capital Markets for Anupam Rasayan's open offer. The offer is for up to 2,77,26,848 equity shares at ₹ 299.00 per share, representing 26.00% of the expanded voting share capital.
⚖️ Strengths & Concerns
✅ Positives
- The DLOF indicates the open offer is not conditional, providing clarity on the acquisition process for shareholders.
- The offer is not a competing offer, simplifying the tendering process for public shareholders of Bliss GVS Pharma.
📅 Company Track Record
Previous filings indicated that SBI Capital Markets Ltd submitted a copy of the Draft Letter of Offer on June 09, 2026, for Anupam Rasayan's ₹ 299.00/share open offer for Bliss GVS Pharma. On June 01, 2026, Anupam Rasayan India offered to acquire 26.00% of Bliss GVS Pharma at the same price.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the purpose of the Draft Letter of Offer received by Bliss GVS Pharma?
The Draft Letter of Offer (DLOF) outlines the detailed terms and conditions of the open offer made by Anupam Rasayan India Limited to the public shareholders of Bliss GVS Pharma Limited.
How many shares is Anupam Rasayan India Limited offering to acquire in Bliss GVS Pharma?
Anupam Rasayan India Limited is offering to acquire up to 2,77,26,848 fully paid-up equity shares of Bliss GVS Pharma Limited.
What is the offer price per equity share in the open offer for Bliss GVS Pharma?
The offer price is ₹ 299.00 (Indian Rupees Two Hundred Ninety-Nine Only) per equity share in the open offer.
What percentage of Bliss GVS Pharma's capital does this open offer represent?
The open offer represents 26.00% (Twenty-Six per cent) of the expanded voting share capital of Bliss GVS Pharma Limited.
Who is the Manager to the Open Offer for Bliss GVS Pharma?
SBI Capital Markets Limited is the Manager to the Open Offer for Bliss GVS Pharma Limited, as indicated in the filing.
Questions based on this BSE filing only. For information purposes.